Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> SANOFI Latest News

2 HOURS AGO - Yahoo! News

A Must Read - Share

Sanofi diabetes drug Toujeo wins EU green light, pricing in focus

By Ben Hirschler LONDON (Reuters) - French drugmaker Sanofi's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared for sale in the United States, regulators said on Friday. The positive decision from experts at the European Medicines Agency (EMA) had been expected and paves the way for the long-lasting insulin product to be ...

Tags: Sanofi diabetes drug Toujeo wins EU green light, pricing in focus,  Sanofi Latest News

3 HOURS AGO - Yahoo! News

A Must Read - Share

Sanofi diabetes drug Toujeo wins European green light

French drugmaker Sanofi's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared to go on sale in the United States, regulators said on Friday. The positive decision from a committee of experts at the European Medicines Agency had been expected and will pave the way for the long-lasting insulin product to go on ...

Tags: Sanofi diabetes drug Toujeo wins European green light,  Sanofi Latest News

18 HOURS AGO - Health Canal

A Must Read - Share

Small Molecule Helps Get Stem Cells to Sites of Disease and Damage

Bioengineers from Brigham and Women’s Hospital (BWH) with collaborators at the pharmaceutical company Sanofi have identified small molecules that can be used to program stem cells to home in on sites of damage, disease and inflammation.

Tags: Small Molecule Helps Get Stem Cells to Sites of Disease and Damage,  Sanofi Latest News

19 HOURS AGO - MedPage Today

A Must Read - Share

FDA Oks Lantus Follow-Up

(MedPage Today) -- Sanofi gets green light as patent on its top-selling insulin is set to expire.

Tags: FDA Oks Lantus Follow-Up,  Sanofi Latest News

23 HOURS AGO - Yahoo! News

A Must Read - Share

Sanofi diabetes drug awaits imminent EU green light

By Ben Hirschler LONDON (Reuters) - Sanofi's new Toujeo diabetes drug is on track to receive a potential green light from European regulators this week, building on a U.S. regulatory approval awarded on Wednesday. Toujeo is a more potent follow-up to the French drugmaker's top-selling Lantus insulin product, which accounts for a fifth of group sales, and the new drug ...

Tags: Sanofi diabetes drug awaits imminent EU green light,  Sanofi Latest News